bioAffinity Technologies, Inc.
Develops noninvasive diagnostics and targeted therapeutics for cancer.
BIAF | US
Overview
Corporate Details
- ISIN(s):
- CA09064N1033 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 3300 NACOGDOCHES ROAD, 78217 SAN ANTONIO
- Website:
- https://bioaffinitytech.com/
Description
bioAffinity Technologies, Inc. is a company focused on developing noninvasive diagnostics and targeted therapeutics for cancer. Its first commercialized product, CyPath® Lung, is a non-invasive laboratory developed test for the early detection of lung cancer. The test is designed for individuals at high risk who have suspicious but indeterminate findings on a low-dose computed tomography (LDCT) scan. CyPath® Lung analyzes patient sputum samples using an automated flow cytometry platform and machine learning to identify cell populations indicative of cancer. This approach aims to improve diagnostic accuracy, reduce unnecessary invasive procedures, and lower associated healthcare costs. The company's core technology is based on a proprietary porphyrin platform that preferentially targets cancer cells, with ongoing research to expand its application to other diagnostics and therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all bioAffinity Technologies, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioAffinity Technologies, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioAffinity Technologies, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||